Skip to main content

Pulmonary HTN

The main principles of treatment encompass:
  • providing supplemental oxygen to help avoid hypoxemia, and to improve oxygenation,
  • anticoagulation for the prevention of further pulmonary emboli, and
  • vasodilatory therapy to reverse the vasoconstrictive component of pulmonary hypertension.
The goal of oxygen therapy (supplementation) is to maintain oxygen saturation over 90% at all times to attenuate hypoxic pulmonary vasoconstriction. Therefore, supplemental oxygen may be necessary during periods of exertion or at rest as well.

Long term Coumadin (warfarin) therapy has been shown to improve survival of the patients suffering from primary pulmonary hypertension . Prothrombin time needs to be monitored and the desirable level of anticoagulation is to keep the INR level between 2-3.

For the reversal of pulmonary vasoconstrictive component of pulmonary hypertension (if present) both calcium channel blockers and prostacyclines have been used with somewhat limited success. The goal of vasodilatory therapy is to reduce mean pulmonary artery pressures at least 20% below the pretreatment level, and to improve cardiac output without inducing systemic hypotension.

Of the calcium channel blockers both nifedipine and diltiazem have been used for long term oral treatment (they have lesser negative inotropic effects than other calcium channel blockers).

Unfortunately, only about 25-26% of the patients respond favorably to this treatment. Studies show that patients who respond favorably have a 5 year survival of 94% compared to 55% for dose who do not respond to calcium channel blockers .

 The usual doses of nifedipine range between 120-240 mg/day (sustained release formula), but doses as high as 900 mg/day of diltiazem have been used.

  1. Arroliga, AC et al., in Chest Medicine, Essentials of Pulmonary and Critical Care Medicine, Eds: George, Light, Matthay and Matthay, Lippincott, William and Wilkins 2000, pp. 233-262
  2. Rubin, LJ, NEJM, 1998, 336:111-117
Labels:

Comments

Post a Comment

Popular posts from this blog

power injectable peripherally inserted central catheters

Clinical experience with power injectable peripherally inserted central catheters in intensive care patients     Introduction In intensive care units (ICU), peripherally inserted central catheters (PICC) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome by the use of power-injectable catheters . Method We have retrospectively reviewed all the power injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. Results We have collected 89 power injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related blood stream infection. Non-infective complications ...
1 comment
Read more

The 12 decision making steps for post dural puncture headache treatment

Treatment decision-making algorithm for postdural puncture headache. 1. When diagnosis is made, all patients should receive supportive measures (reassurance, bed rest, analgesics, hydration, quiet environment). 2. Severity of symptoms should be classified using VAS scale (mild 1–3, moderate 4–6, severe 7–10). 3. Virtually all patients will improve in time even without additional therapy. (dashed lines) 4. Symptoms worsen or fail to resolve within 5 days. 5. Patient preference dictates the choice between pharmacologic (less effective) and epidural blood patch (EBP). 6. In patients with severe symptoms, EBP is strongly suggested. 7. The most common pharmacologic measure is  caffeine  prescription. 8. The failure, worsening, or recurrence of symptoms after pharmacologic measures favors the use of EBP. 9. In addition to EBP, other epidural treatment options can be considered in select patients (eg,  dextran , saline). 10. A period of 24 h should lapse before repeating EBP. 11...
1 comment
Read more

Things to Avoid in Anesthesia for Pregnant with Pulmonary hypertension

Anesthesia for Pregnant woman with Pulmonary Hypertension is a real challenge for anesthesiologist. It is very crucial to remember the pathophysiology of pulmonary hypertension in pregnant women and to avoid some practices that will worsen the cardiac status. 1-Avoid single shot spinal anesthesia. Some authorities consider pulmonary hypertension as absolute contraindication for single shot spinal anesthesia specially in patients with NYHA III ,IV. Spinal anesthesia causes major hemodynamic instability(decrease SVR, decrease VR, decrease in CO) The preferred neuroaxial techniques are (epidural anesthesia and CSE with minimal spinal dose) 2-Avoid PAC. Pulmonary Artery catheters insertion may lead to pulmonary artery rupture or thrombosis. TEE is better cardiac monitor/Arteial line is mandatory. 3-Avoid Nitrous oxide in gas mixture.N2O increase the PVR 4-If MV to be started, avoid High TV and PEEP 5-Avoid Oxytocin Boluses, or rapid administration of Pitocin. Oxytocin causes ...
Post a Comment
Read more